NCT02373072: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 in Subjects With Idiopathic Parkinson's Disease
- State
- Completed
- Phase
- Phase 1
- People
- 18 taking part
- Started
- Mar 2015
- Primary completion
- Feb 2016
- Arms
- Cohort 1, Cohort 2
- Results
- None posted
- 26 Feb 2015: Trial registered